Mkts

Anavex Life Sciences Corp.

NASDAQ: AVXL
$0.63-0.04 (-6.22%)
As of Nov 20, 2:15 PM ET

Key statistics

Day range
0.620.71
52-week range
0.715.36
Today
Open0.68
Previous close0.63
Volume516.6K
Valuation
Market cap61.97M
P/E ratio—
EPS (TTM)-0.15
Income & risk
Dividend / yield—
Beta1.41
Avg volume1.07M
Discussion

AVXL News

Stories mentioning AVXL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30Q1 '24Mar 31
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development4,6567,2959,9599,89210,44611,61411,8119,729
Sales General & Admin2,1263,146
Total Operating Expenses6,78210,84414,45912,51313,59214,27214,60312,624
Operating Income (Loss)(6,782)(10,844)(14,459)(12,513)(13,592)(14,272)(14,603)(12,624)
Interest Income
Interest Expense
Other Expense
Pretax Income(11,743)(12,281)(10,441)
Tax Provision18.00
Net Income (Loss)(5,681)(9,827)(13,243)(11,196)(12,111)(11,620)(12,214)(10,546)
Earnings Per Share (Basic)(0.06)(0.12)(0.16)(0.13)(0.14)(0.14)(0.14)(0.13)
Earnings Per Share (Diluted)(0.06)(0.12)(0.16)(0.13)(0.14)(0.14)(0.14)(0.13)
Weighted Average Shares Outstanding (Basic)89,02985,28985,38185,07484,80683,46884,53582,464
Weighted Average Shares Outstanding (Diluted)89,02985,28985,38185,07484,80683,46884,53582,464

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AVXL

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a stock listed on the Nasdaq Stock Market under the ticker symbol AVXL. It last traded at $0.6300 (Nov 20, 2026, 2:15 PM ET), down 6.2% on the day. That gives Anavex Life Sciences a market capitalisation of $62.0M.

Over the past 52 weeks AVXL has traded between $0.7100 and $5.36.

For the quarter ended Dec 31, 2025 it reported a net loss of $5.7M.

Last 4 quarters
Quarter endedRevenueNet income
Dec 31, 2025—-$5.7M
Sep 30, 2025—-$9.8M
Jun 30, 2025—-$13.2M
Mar 31, 2025—-$11.2M

From Anavex Life Sciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…